Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas.

Sandra Cantilena; Fabio Pastorino; Olesya Chayka; Annalisa Pezzolo; Vito Pistoia; Mirco Ponzoni; Arturo Sala

doi:10.18632/oncotarget.410

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Brief Reports:

Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas.

Sandra Cantilena, Fabio Pastorino, Olesya Chayka, Annalisa Pezzolo, Vito Pistoia, Mirco Ponzoni and Arturo Sala _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2011; 2:976-983. https://doi.org/10.18632/oncotarget.410

Metrics: PDF 3147 views | HTML 4237 views | ?

Abstract

Sandra Cantilena^1,4, Fabio Pastorino^3,4, Annalisa Pezzolo³, Olesya Chayka¹, Vito Pistoia³, Mirco Ponzoni³ and Arturo Sala^1,2

¹ Molecular Haematology and Cancer Biology Unit, UCL Institute of Child Health, 30 Guilford st London WC1N 1EH London UK

² Brunel Institute of Cancer Genetics and Pharmacogenomics, Brunel University, Uxbridge, Middlesex UB8 3PH, UK

³Laboratory of Oncology, G. Gaslini Institute, Largo G. Gaslini 5, 16147 Genova, Italy

⁴Denotes equal contribution

Received: December 30, 2011; Accepted: December 30, 2011; Published: December 31, 2011;

Keywords: HIF, hypoxia, metastasis, neuroblastoma, stem cell

Correspondence:

Arturo Sala, email:

Mirco Ponzoni, email:

Abstract

Wnt signalling is an important component of vertebrate development, required for specification of the neural crest. Ten Wnt receptors [Frizzled receptor 1-10 (Fzd1-10)] have been identified so far, some of which are expressed in the developing nervous system and the neural crest. Here we show that expression of one such receptors, Fzd6, predicts poor survival in neuroblastoma patients and marks rare, HIF1/2 α-positive cells in tumour hypoxic areas. Fzd6 positive neuroblastoma cells form neurospheres with high efficiency, are resistant to doxorubicin killing and express high levels of mesenchymal markers such as Twist1 and Notch1. Expression of Fzd6 is required for the expression of genes of the non-canonical Wnt pathway and the spheres forming activity. When transplanted into immunodeficient mice, neuroblastoma cells expressing the Fzd6 marker grow more aggressively than their Fzd6 negative counterparts. We conclude that Fzd6 is a new surface marker of aggressive neuroblastoma cells with stem cell-like features.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 410

Publication Alerts

Brief Reports:

Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas.

Abstract